Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Prospective Randomized-controlled Interventional Study to Evaluate the Effect of High Dose Rosuvastatin Versus High Dose Rosuvastatin and Ezetimibe in Acute Ischemic Stroke Patients

NCT05884502 is registered in ClinicalTrials.gov with Korea University Anam Hospital as lead sponsor.

NCT NCT05884502
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05884502 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Prospective Randomized-controlled Interventional Study to Evaluate the Effect of High Dose Rosuvastatin Versus High Dose Rosuvastatin and Ezetimibe in Acute Ischemic Stroke Patients
Lead sponsor
Korea University Anam Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
September 1, 2022
Completion date
December 31, 2024
Enrollment
330 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

dyslipidemias, stroke, acute ischemic